[Not Yet Scheduled]
At Ferrer we want to promote a new way of doing business and a responsible way of being in the world. We want to make a positive impact in society while running a successful pharmaceutical enterprise. Our business is not an end in itself, but a means to generate positive global impact. Our conviction is such that the company's strategic plan consists of three pillars that define what we want to achieve: great people, a livable planet, and social justice. In its mission, Ferrer has exceeded global B Corp standards in terms of social and environment performance, transparency, and corporate responsibility - and in all the territories for which it has a direct presence. Over the last four years, the company has placed increasing focus on achieving transformation as a positive global and social impact organization. Our purpose, our strategy and our achievements are present in our corporate identity and slogan: "Ferrer for good".
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Tyvaso (inhaled treprostinil) for Pulmonary Hypertension - Interstitial Lung Disease, in Europe
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):